In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Johnson & Johnson (JNJ – Research Report), ...

Fintel reports that on January 22, 2025, RBC Capital downgraded their outlook for Intra-Cellular Therapies (NasdaqGS:ITCI) ...

RBC Capital analyst Brian Abrahams maintained a Hold rating on Incyte (INCY – Research Report) on January 21 and set a price target of $70.00.

Each year, RBC supports thousands of students from different educational backgrounds in exploring various career paths within ...

Fintel reports that on January 21, 2025, RBC Capital downgraded their outlook for CF Industries Holdings (NYSE:CF) from ...

However, its 2025 costs and capital expenditure guidance exceeded analyst expectations as well as its own previous guidance. For full-year 2025, Hochschild expects capital expenditure between $197 ...

CF Industries Holdings, Inc. (CF) stock saw a decline, ending the day at $93.66 which represents a decrease of $-3.35 or -3.45% from the prior close of $97.01. The stock opened at $95.5 and touched a ...

GE Aerospace (GE) is set to announce Q4 earnings, with analysts focused on engine deliveries, margins, and aftermarket growth ...

Though many households are faltering on credit card and auto loan payments, wealthier Americans are keeping the spending metrics robust.

On Tuesday, Aramark (ARMK) stock saw a decline, ending the day at $38.59 which represents a decrease of $-0.57 or -1.46% from the prior close of $39.16. The stock opened at $39.46 and touched a low of ...

Shares in Adidas climbed after the company beat its own profit expectations amid fierce competition in the sector and as its biggest rival, Nike, continues to pursue a brand revamp strategy.